TL;DR: BAS 00335741 (CAS 179946-04-4) is a chemical compound with molecular formula C22H26N2O and molecular weight 334.2045 g/mol, supplied by CoreyChem (Career Henan Chemical Co., Ltd.) with ISO-certified quality and global shipping.
spiro[3,10-diazatetracyclo[9.8.0.03,9.012,17]nonadeca-1(11),9,12,14,16-pentaene-19,1'-cyclohexane]-2-one
Also Known As: BAS 00335741, 10,11,12,13-tetrahydro-5H-spiro[azepino[2,1-b]benzo[h]quinazoline-6,1'-cyclohexan]-7(9H)-one, spiro[5,6,8-trihydro-9H,10H,11H,12H,13H-azaperhydroepino[2,1-b]benzo[h]quinazo line-6,1'-cyclohexane]-7-one
| Molecular Formula | C22H26N2O |
| Molecular Weight | 334.2045 g/mol |
| XLogP | 4.5 |
| Topological Polar Surface Area (TPSA) | 32.7 Ų |
| Hydrogen Bond Donors | 0 |
| Hydrogen Bond Acceptors | 2 |
| Rotatable Bonds | 0 |
| Exact Mass | 334.2045 Da |
| Heavy Atoms | 25 |
| Complexity | 626.0 |
| SMILES | C1CCC2=NC3=C(C(=O)N2CC1)C4(CCCCC4)CC5=CC=CC=C53 |
| InChIKey | DTKMVWZKEUHMRJ-UHFFFAOYSA-N |
The XLogP value of 4.5 indicates that BAS 00335741 is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. With a topological polar surface area (TPSA) of 32.7 Ų, BAS 00335741 exhibits relatively low polarity, potentially indicating favorable cell membrane permeability. Following Lipinski's Rule of Five, BAS 00335741 has 0 hydrogen bond donor(s) and 2 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
The CAS number of BAS 00335741 is 179946-04-4.
The molecular formula of BAS 00335741 is C22H26N2O.
The molecular weight of BAS 00335741 is 334.2045 g/mol.
You can request a quote for BAS 00335741 directly from CoreyChem. Contact us or email [email protected] for pricing and availability.
Yes, CoreyChem provides custom synthesis services for BAS 00335741 and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.
Request a quote for CAS 179946-04-4. Our professional technical team will respond with pricing and lead time.